Birken et al 22 recently reported on a qualitative study that investigated strategies to improve the implementation of care plans. By using data reported as part of the Quality Oncology Practice ...
SELECT: A Phase II Trial of Adjuvant Erlotinib in Patients With Resected Epidermal Growth Factor Receptor–Mutant Non–Small-Cell Lung Cancer Research suggests that overuse—including overscreening, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback